Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction

International Journal of Cardiology

Volumn 138, Issue 1, 2010, Pages 9-18

  Enoki, Chiharu ^a   Otani, Hajime ^a   Sato, Daisuke ^a   Okada, Takayuki ^a   Hattori, Reiji ^a   Imamura, Hiroji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell transplantation; Insulin like growth factor 1; Mesenchymal cells; Myocardial infarction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GREEN FLUORESCENT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY LIGATION; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DOSE RESPONSE; ECHOCARDIOGRAPHY; ENGRAFTMENT; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HYPOXIA; IN VITRO STUDY; LEFT CORONARY ARTERY; MESENCHYME CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; TRANSPLANTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANOXIA; APOPTOSIS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CXCL12; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; INSULIN-LIKE GROWTH FACTOR I; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT;

EID: 70749095115     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.04.012     Document Type: Article

References (49)

1. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
2. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
3. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
4. Perin E.C., Dohmann H.F., Borojevic R., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 11 Suppl 1 (2004) II213-8
5. Tatsumi T., Ashihara E., Yasui T., et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circulation J 71 (2007) 1199-1207
6. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
7. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002 4) 41-49
8. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
9. Hattan N., Kawaguchi H., Ando K., et al. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res 65 (2005) 334-344
10. Kawada H., Fujita J., Kinjo K., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104 (2004) 3581-3587
11. Reinecke H., Zhang M., Bartosek T., and Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100 (1999) 193-202
12. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., and Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
13. Müller-Ehmsen J., Krausgrill B., Burst V., et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41 (2006) 876-884
14. Gojo S., Gojo N., Takeda Y., et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288 (2003) 51-59
15. Shake J.G., Gruber P.J., Baumgartner W.A., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73 (2002) 1919-1925
16. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
17. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 (1998) 262-267
18. Ruggero D., and Sonenberg N. The Akt of translational control. Oncogene 24 (2005) 7426-7434
19. Grimberg A. Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2 (2003) 630-635
20. Urbanek K., Rota M., Cascapera S., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97 (2005) 663-673
21. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
22. Stephens L., Anderson K., Stokoe D., et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279 (1998) 710-714
23. Pradip D., Peng X., and Durden D.L. Rac2 specificity in macrophage integrin signaling: potential role for Syk kinase. J Biol Chem 278 (2003) 41661-41669
24. Song L., and Tuan R.S. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18 (2004) 980-982
25. Mieno S., Ramlawi B., Boodhwani M., et al. Role of stromal-derived factor-1 alpha in the induction of circulating CD34+CXCR4+ progenitor cells after cardiac surgery. Circulation 114 (2006) I186-I192
26. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124 (2006) 18-21
27. Bartunek J., Croissant J.D., Wijns W., et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 292 (2007) H1095-H1104
28. Hahn J.Y., Cho H.J., Kang H.J., et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51 (2008) 933-943
29. Guo J., Lin G., Bao C., Hu Z., Chu H., and Hu M. Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. J Biomed Sci 15 (2008) 89-97
30. Kofidis T., de Bruin J.L., Yamane T., et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22 (2004) 1239-1245
31. Li Q., Li B., Wang X., et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100 (1997) 1991-1999
32. Davis M.E., Hsieh P.C., Takahashi T., et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 103 (2006) 8155-8160
33. Gharbi S.I., Zvelebil M.J., Shuttleworth S.J., et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J 404 (2007) 15-21
34. Melikova S., Dylla S.J., and Verfaillie C.M. Phosphatidylinositol-3-kinase activation mediates proline-rich tyrosine kinase 2 phosphorylation and recruitment to beta1-integrins in human CD34+ cells. Exp Hematol 32 (2004) 1051-1056
35. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61 (2004) 448-460
36. Haider H.K., Jiang S., Idris N.M., and Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1α/CXCR4 signaling to promote myocardial repair. Circ Res 103 (2008) 1300-1308
37. Li Y., Yu X., Lin S., Li X., Zhang S., and Song Y.H. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356 (2007) 780-784
38. Fukuda K. Application of mesenchymal stem cells for the regeneration of cardiomyocyte and its use for cell transplantation therapy. Hum Cell 16 (2003) 83-94
39. Shim W.S., Jiang S., Wong P., et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 324 (2004) 481-488
40. Li X., Yu X., Lin Q., et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol 42 (2007) 295-303
41. Jiang W., Ma A., Wang T., et al. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch 453 (2006) 43-52
42. Gallo M.P., Ramella R., Alloatti G., et al. Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes. J Cell Biochem 100 (2007) 86-99
43. Noiseux N., Gnecchi M., Lopez-Ilasaca M., et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Molec Ther 14 (2006) 840-850
44. Singla D.K., Lyons G.E., and Kamp T.J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293 (2007) H1308-H1314
45. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
46. Tang Y.L., Zhao Q., Qin X., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80 (2005) 229-236
47. Kinnaird T., Stabile E., Burnett M.S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109 (2004) 1543-1549
48. Iwase T., Nagaya N., Fujii T., et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 66 (2005) 543-551
49. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150